The Nature and Treatment of Anxiety Disorders |
From inside the book
Results 1-3 of 51
Page 129
... benzodiazepines longer than two months is likely to show some signs of withdrawal upon discontinuation . More severe with- drawal reactions have been associated with the abrupt withdrawal of the short - acting benzodiazepines , but it ...
... benzodiazepines longer than two months is likely to show some signs of withdrawal upon discontinuation . More severe with- drawal reactions have been associated with the abrupt withdrawal of the short - acting benzodiazepines , but it ...
Page 130
... benzodiazepine use , the issue remains cloudy . There is evidence that benzodiazepines provide benefit to very anxious patients , yet only 25 percent of pa- tients with anxiety disorders are being treated with a BZ medication . On the ...
... benzodiazepine use , the issue remains cloudy . There is evidence that benzodiazepines provide benefit to very anxious patients , yet only 25 percent of pa- tients with anxiety disorders are being treated with a BZ medication . On the ...
Page 307
... benzodiazepines . A number of substances , chemically unrelated to the benzodiazepines , possess preclinical pro- files suggestive of anxiolytic effects ( Gershon and Eison , 1987 ) . One of these groups , the azaspirodecanediones was ...
... benzodiazepines . A number of substances , chemically unrelated to the benzodiazepines , possess preclinical pro- files suggestive of anxiolytic effects ( Gershon and Eison , 1987 ) . One of these groups , the azaspirodecanediones was ...
Contents
Theories of Anxiety | 15 |
Anxiety Syndromes and Disorders | 43 |
An Overview of Symptom | 69 |
Copyright | |
13 other sections not shown
Other editions - View all
Common terms and phrases
activity acute agoraphobia agoraphobic agoraphobic patients alcohol alprazolam antidepressants anxiety disorders anxiolytic anxious patients arousal assessment associated avoidance behavior therapy Behaviour Research benzodiazepines buspirone BZDs cause changes chapter clinical cognitive therapy common coping criteria depression developed diagnosis diazepam discussed dose drive drugs DSM-III-R evaluation experience experienced exposure therapy factors feeling frequently function heart rate hyperventilation iety imipramine important increased intensity intervention involved Journal of Psychiatry Joyce lactate locus coeruleus lorazepam MAOI measures medication ment months muscle occur onset panic attacks panic disorder panic disorder patients patients with panic percent person phenelzine physiologic practice present problems procedure propanolol Psychiatry psychological psychotherapy reduce relaxation reported Research and Therapy response self-efficacy self-statements sensations session side effects simple phobias social phobia social phobics somatic stimuli stress studies syndrome tasks TCAs theory therapeutic therapist thoughts tients tion treat treatment vivo exposure walk weeks withdrawal worry